Azithromycin use in pediatric pityriasis lichenoides: a brief retrospective review
Abstract Pityriasis Lichenoides Chronica (PLC) and Pityriasis Lichenoides et Varioliformis Acuta (PLEVA) are rare conditions characterized by inflammatory skin lesions with unclear etiology [1,2]. Standard treatments include antibiotics, steroids, methotrexate, and phototherapy [1,3,4,5]. This retrospective chart review compares azithromycin to other standard treatments to assess its safety and effectiveness. Results demonstrated no detectable difference from standard treatments, with the additional advantage of less frequent dosing.
Authors
- Kalyani S. Marathe (ORCID: https://orcid.org/0000-0001-8207-4019)
- Coleman Yamakoshi
- Alexa DeRegnaucourt (ORCID: https://orcid.org/0009-0004-3602-9232)
- Isaiah Holt
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Archives of Dermatological Research
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1007/s00403-026-05016-5
- Primary Topic
- Medicine and Dermatology Studies History
- Type
- article
- Field-Weighted Citation Impact
- 0.00